Logo image of AQNB

ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079 (AQNB) Stock Fundamental Analysis

NYSE:AQNB - New York Stock Exchange, Inc. - US0158578080 - Currency: USD

26.13  +0.5 (+1.95%)

Fundamental Rating

3

Overall AQNB gets a fundamental rating of 3 out of 10. We evaluated AQNB against 25 industry peers in the Multi-Utilities industry. There are concerns on the financial health of AQNB while its profitability can be described as average. AQNB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year AQNB was profitable.
AQNB had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AQNB reported negative net income in multiple years.
In the past 5 years AQNB always reported a positive cash flow from operatings.
AQNB Yearly Net Income VS EBIT VS OCF VS FCFAQNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

Looking at the Return On Assets, with a value of -9.49%, AQNB is doing worse than 96.00% of the companies in the same industry.
With a Return On Equity value of -27.63%, AQNB is not doing good in the industry: 96.00% of the companies in the same industry are doing better.
AQNB has a Return On Invested Capital (3.93%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for AQNB is in line with the industry average of 3.93%.
The last Return On Invested Capital (3.93%) for AQNB is above the 3 year average (2.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -9.49%
ROE -27.63%
ROIC 3.93%
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
AQNB Yearly ROA, ROE, ROICAQNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

AQNB has a Operating Margin (21.00%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of AQNB has declined.
With a decent Gross Margin value of 73.47%, AQNB is doing good in the industry, outperforming 72.00% of the companies in the same industry.
AQNB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21%
PM (TTM) N/A
GM 73.47%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
AQNB Yearly Profit, Operating, Gross MarginsAQNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

AQNB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AQNB has more shares outstanding
Compared to 5 years ago, AQNB has more shares outstanding
Compared to 1 year ago, AQNB has an improved debt to assets ratio.
AQNB Yearly Shares OutstandingAQNB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AQNB Yearly Total Debt VS Total AssetsAQNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

AQNB has an Altman-Z score of 1.43. This is a bad value and indicates that AQNB is not financially healthy and even has some risk of bankruptcy.
AQNB has a Altman-Z score of 1.43. This is amongst the best in the industry. AQNB outperforms 100.00% of its industry peers.
AQNB has a Debt/Equity ratio of 1.28. This is a high value indicating a heavy dependency on external financing.
With a decent Debt to Equity ratio value of 1.28, AQNB is doing good in the industry, outperforming 64.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF N/A
Altman-Z 1.43
ROIC/WACC0.57
WACC6.94%
AQNB Yearly LT Debt VS Equity VS FCFAQNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.16 indicates that AQNB should not have too much problems paying its short term obligations.
With an excellent Current ratio value of 1.16, AQNB belongs to the best of the industry, outperforming 84.00% of the companies in the same industry.
AQNB has a Quick Ratio of 1.16. This is a bad value and indicates that AQNB is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.97, AQNB belongs to the top of the industry, outperforming 88.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.97
AQNB Yearly Current Assets VS Current LiabilitesAQNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

AQNB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.49%.
AQNB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.38% yearly.
AQNB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.38%.
The Revenue has been growing slightly by 7.38% on average over the past years.
EPS 1Y (TTM)-24.49%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%0%
Revenue 1Y (TTM)13.38%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%-6.06%

3.2 Future

Based on estimates for the next years, AQNB will show a small growth in Earnings Per Share. The EPS will grow by 6.99% on average per year.
Based on estimates for the next years, AQNB will show a small growth in Revenue. The Revenue will grow by 2.30% on average per year.
EPS Next Y-20.16%
EPS Next 2Y-0.53%
EPS Next 3Y0.93%
EPS Next 5Y6.99%
Revenue Next Year-9.8%
Revenue Next 2Y-3.24%
Revenue Next 3Y-0.5%
Revenue Next 5Y2.3%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AQNB Yearly Revenue VS EstimatesAQNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AQNB Yearly EPS VS EstimatesAQNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

0

4. Valuation

4.1 Price/Earnings Ratio

AQNB is valuated quite expensively with a Price/Earnings ratio of 70.62.
Based on the Price/Earnings ratio, AQNB is valued more expensive than 92.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.45, AQNB is valued quite expensively.
Based on the Price/Forward Earnings ratio of 71.37, the valuation of AQNB can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AQNB indicates a rather expensive valuation: AQNB more expensive than 96.00% of the companies listed in the same industry.
AQNB's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.90.
Industry RankSector Rank
PE 70.62
Fwd PE 71.37
AQNB Price Earnings VS Forward Price EarningsAQNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AQNB is valued expensively inside the industry as 96.00% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.48
AQNB Per share dataAQNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.53%
EPS Next 3Y0.93%

6

5. Dividend

5.1 Amount

AQNB has a Yearly Dividend Yield of 4.60%, which is a nice return.
Compared to an average industry Dividend Yield of 3.76, AQNB pays a better dividend. On top of this AQNB pays more dividend than 96.00% of the companies listed in the same industry.
AQNB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 4.6%

5.2 History

The dividend of AQNB has a limited annual growth rate of 0.06%.
AQNB has been paying a dividend for over 5 years, so it has already some track record.
AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.06%
Div Incr Years1
Div Non Decr Years4
AQNB Yearly Dividends per shareAQNB Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

AQNB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
AQNB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-20.99%
EPS Next 2Y-0.53%
EPS Next 3Y0.93%
AQNB Yearly Income VS Free CF VS DividendAQNB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

26.13

+0.5 (+1.95%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-07 2025-08-07
Inst Owners72.96%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap20.06B
Analysts53.33
Price Target21.21 (-18.83%)
Short Float %0%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield 4.6%
Yearly Dividend0.41
Dividend Growth(5Y)0.06%
DP-20.99%
Div Incr Years1
Div Non Decr Years4
Ex-Date06-13 2025-06-13 (0.5475)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.21%
Min EPS beat(2)-25.74%
Max EPS beat(2)42.17%
EPS beat(4)2
Avg EPS beat(4)3.68%
Min EPS beat(4)-25.74%
Max EPS beat(4)42.17%
EPS beat(8)3
Avg EPS beat(8)-2.73%
EPS beat(12)5
Avg EPS beat(12)-3.23%
EPS beat(16)6
Avg EPS beat(16)-2.32%
Revenue beat(2)1
Avg Revenue beat(2)0.35%
Min Revenue beat(2)-4.61%
Max Revenue beat(2)5.31%
Revenue beat(4)1
Avg Revenue beat(4)-1.14%
Min Revenue beat(4)-5.17%
Max Revenue beat(4)5.31%
Revenue beat(8)3
Avg Revenue beat(8)-2.03%
Revenue beat(12)7
Avg Revenue beat(12)0.37%
Revenue beat(16)10
Avg Revenue beat(16)2.48%
PT rev (1m)9.5%
PT rev (3m)5.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.11%
EPS NY rev (1m)0%
EPS NY rev (3m)3.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.72%
Valuation
Industry RankSector Rank
PE 70.62
Fwd PE 71.37
P/S 6.66
P/FCF N/A
P/OCF 47.22
P/B 4.27
P/tB 6.06
EV/EBITDA 24.48
EPS(TTM)0.37
EY1.42%
EPS(NY)0.37
Fwd EY1.4%
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)0.55
OCFY2.12%
SpS3.92
BVpS6.11
TBVpS4.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.49%
ROE -27.63%
ROCE 4.97%
ROIC 3.93%
ROICexc 3.95%
ROICexgc 4.44%
OM 21%
PM (TTM) N/A
GM 73.47%
FCFM N/A
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
ROICexc(3y)2.37%
ROICexc(5y)2.33%
ROICexgc(3y)2.6%
ROICexgc(5y)2.56%
ROCE(3y)2.99%
ROCE(5y)2.93%
ROICexcg growth 3Y4.3%
ROICexcg growth 5Y-5.03%
ROICexc growth 3Y4.14%
ROICexc growth 5Y-4.63%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
F-Score5
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF N/A
Debt/EBITDA 5.61
Cap/Depr 199.46%
Cap/Sales 29.3%
Interest Coverage 1.53
Cash Conversion 39.53%
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 0.97
Altman-Z 1.43
F-Score5
WACC6.94%
ROIC/WACC0.57
Cap/Depr(3y)213.94%
Cap/Depr(5y)245.17%
Cap/Sales(3y)39.89%
Cap/Sales(5y)45.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.49%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%0%
EPS Next Y-20.16%
EPS Next 2Y-0.53%
EPS Next 3Y0.93%
EPS Next 5Y6.99%
Revenue 1Y (TTM)13.38%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%-6.06%
Revenue Next Year-9.8%
Revenue Next 2Y-3.24%
Revenue Next 3Y-0.5%
Revenue Next 5Y2.3%
EBIT growth 1Y26.92%
EBIT growth 3Y4.45%
EBIT growth 5Y4.06%
EBIT Next Year44.64%
EBIT Next 3Y17.99%
EBIT Next 5YN/A
FCF growth 1Y-3.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.77%
OCF growth 3Y45.17%
OCF growth 5Y-4.65%